Binbin Lu
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
-
- Natural Compounds in Disease Treatment
Papers in
-
- Nanoparticle-Based Drug Delivery 5
-
- Angiogenesis and VEGF in Cancer 5
- RNA Interference and Gene Delivery 4
- RNA modifications and cancer 2
- RNA Research and Splicing 1
- Co-authors
- Zhengfang Yi (5 shared papers)Mingyao Liu (5 shared papers)Weijing Qu (2 shared papers)Xiufeng Pang (2 shared papers)Yanmin Dong (3 shared papers)Jing Zhang (1 shared paper)Bharat Bhushan Aggarwal (1 shared paper)Bokyung Sung (1 shared paper)
- Journals
- International Journal of Pharmaceutics (3 papers)Angiogenesis (1 paper)Molecular Cancer Therapeutics (1 paper)Parasites & Vectors (1 paper)International Journal of Nanomedicine (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Binbin Lu
16 papers receiving 698 citations
Peers
Comparison fields: 5 of 63
- Toxicology 67
- Complementary and alternative medicine 117
- Drug Discovery 3
- Biomaterials 74
- Molecular Biology 291
Countries citing papers authored by Binbin Lu
This map shows the geographic impact of Binbin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binbin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binbin Lu more than expected).
Fields of papers citing papers by Binbin Lu
This network shows the impact of papers produced by Binbin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binbin Lu. The network helps show where Binbin Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Binbin Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 203 | |
| 2 | 2012 | 115 | |
| 3 | 2011 | 83 | |
| 4 | 2011 | 75 | |
| 5 | 2011 | 67 | |
| 6 | 2017 | 42 | |
| 7 | 2022 | 23 | |
| 8 | 2016 | 19 | |
| 9 | 2015 | 18 | |
| 10 | 2021 | 18 | |
| 11 | 2017 | 16 | |
| 12 | 2017 | 14 | |
| 13 | 2019 | 9 | |
| 14 | 2018 | 8 | |
| 15 | 2024 | 2 | |
| 16 | 2025 | 2 | |
| 17 | 2025 | 0 |
About Binbin Lu
Binbin Lu is a scholar working on Biomaterials, Molecular Biology, Public Health, Environmental and Occupational Health, Oncology and Pharmaceutical Science, having authored 17 papers that have together received 714 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (5 papers), Angiogenesis and VEGF in Cancer (5 papers), RNA Interference and Gene Delivery (4 papers), Malaria Research and Control (4 papers), RNA modifications and cancer (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Advanced Drug Delivery Systems (1 paper) and RNA Research and Splicing (1 paper). The work is most often cited by research in Toxicology (67 citations), Complementary and alternative medicine (117 citations), Drug Discovery (3 citations), Biomaterials (74 citations) and Molecular Biology (291 citations). Binbin Lu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Zhengfang Yi, Mingyao Liu, Weijing Qu, Xiufeng Pang, Yanmin Dong, Jing Zhang, Bharat Bhushan Aggarwal, Bokyung Sung, Yajuan Song and Fujun Dai. Their work appears in journals such as International Journal of Pharmaceutics, Angiogenesis, Molecular Cancer Therapeutics, Parasites & Vectors and International Journal of Nanomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.